Search
for
Sort by
Research 121–150 of 1000+
- 496 Evaluation of extracts containing red clover using dermal papilla cells in the development of a scalp treatment system targeting hair loss and hair damage
- TOXIC EPIDERMAL NECROLYSIS
- Fatal Toxic Epidermal Necrolysis Associated with Minoxidil
- Anais do II Congresso Nacional Acadêmico de Dermatologia
- Table of Contents
- Norman Orentreich, The Father of Hair Transplantation
- Dermatologic Adverse Events from Cancer Treatments
- Missing Conflict of Interest Disclosure
- Index
- Skin biopsy
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- HAIR LOSS ASSOCIATED WITH ESCITALOPRAM: DO SSRIs AFFECT MELATONIN AT THE HAIR FOLLICLE?
- Comparative study between fractional carbon dioxide laser versus intralesional steroids injection in treatment of alopecia areata
- A case of widespread actinic granuloma with associated drug-induced lupus erythematosus
- Urticariform plaques: delayed hypersensitivity reaction type IV to enoxaparin
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Weight loss regimens that control for carbohydrate quality or quantity: a review
- Harmless Herbs? A Review of the Recent Literature
- Mucocutaneous reactions to chemotherapy
- Gender aspects in skin diseases
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- The spectrum of nephrocutaneous diseases and associations
- The Skin and Subcutaneous Tissues
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Cutaneous manifestations of COVID-19